Literature DB >> 17317363

Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes.

Adam C Salisbury1, Kimberly J Reid, John A Spertus.   

Abstract

Although chronic obstructive pulmonary disease (COPD) is common in patients with myocardial infarction (MI), its association with long-term mortality after MI is controversial and little is known about its influence on patients' health status (symptoms, function, and quality of life). We prospectively enrolled 2,481 patients presenting with MI at 19 United States centers to examine the relations between COPD and patients' long-term mortality, rehospitalization rates, and health status after MI. Patients were administered the disease-specific Seattle Angina Questionnaire and the generic Short Form 12 at baseline and 1 year later. COPD was common (15.6% of patients) and was associated with a substantially greater risk of 1-year mortality (15.8% vs 5.7%, p <0.001) and rehospitalization (48.7% vs 38.6%, p <0.001). After extensive adjustment for baseline differences, patients with COPD had a twofold greater 1-year mortality rate (hazard ratio 2.00, 95% confidence interval [CI] 1.44 to 2.79) and higher rehospitalization rates (hazard ratio 1.22, 95% CI 1.01 to 1.48). Similarly, adjusted 1-year health status was worse in patients with COPD, with lower 1-year Seattle Angina Questionnaire quality-of-life score (-2.53 points, 95% CI -0.25 to -4.81) and Short Form 12 physical component score (-1.83 points, 95% CI -0.43 to -3.24). In addition, COPD was associated with a trend toward a greater prevalence of angina at 1 year (risk ratio 1.12, 95% CI 0.89 to 1.41). In conclusion, patients with COPD have greater mortality, higher rehospitalization rates, and poorer health status 1 year after a MI. Although additional research is needed, clinicians should recognize that patients with COPD are at high risk for poor outcomes after MI.

Entities:  

Mesh:

Year:  2007        PMID: 17317363     DOI: 10.1016/j.amjcard.2006.09.112

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  32 in total

1.  Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction.

Authors:  Artur Dziewierz; Dawid Giszterowicz; Zbigniew Siudak; Tomasz Rakowski; Jacek S Dubiel; Dariusz Dudek
Journal:  Clin Res Cardiol       Date:  2010-05-11       Impact factor: 5.460

2.  Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study.

Authors:  Spyridon Liosis; Timm Bauer; Rudolf Schiele; Helmut Gohlke; Martin Gottwik; Hugo Katus; Georg Sabin; Ralf Zahn; Steffen Schneider; Bernhard Rauch; Jochen Senges; Uwe Zeymer
Journal:  Clin Res Cardiol       Date:  2013-06-06       Impact factor: 5.460

3.  Chronic obstructive pulmonary disease after myocardial infarction in the community.

Authors:  Francesca Bursi; Robert Vassallo; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

4.  Hidden in Plain Sight: Lung Impairment in Ischemic Heart Disease.

Authors:  Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

5.  The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study.

Authors:  Mihaela S Stefan; Raveendhara R Bannuru; Darleen Lessard; Joel M Gore; Peter K Lindenauer; Robert J Goldberg
Journal:  Chest       Date:  2011-12-29       Impact factor: 9.410

6.  Chronic obstructive pulmonary disease and the risk of cardiovascular diseases.

Authors:  Cornelia Schneider; Ulrich Bothner; Susan S Jick; Christoph R Meier
Journal:  Eur J Epidemiol       Date:  2010-02-27       Impact factor: 8.082

7.  Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry.

Authors:  Jonathan R Enriquez; Shailja V Parikh; Faith Selzer; Alice K Jacobs; Oscar Marroquin; Suresh Mulukutla; Vankeepuram Srinivas; Elizabeth M Holper
Journal:  Chest       Date:  2011-04-28       Impact factor: 9.410

8.  Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

Authors:  Nathaniel M Hawkins; Zhen Huang; Karen S Pieper; Scott D Solomon; Lars Kober; Eric J Velazquez; Karl Swedberg; Marc A Pfeffer; John J V McMurray; Aldo P Maggioni
Journal:  Eur J Heart Fail       Date:  2009-01-27       Impact factor: 15.534

Review 9.  Cardiovascular injury and repair in chronic obstructive pulmonary disease.

Authors:  William Macnee; John Maclay; David McAllister
Journal:  Proc Am Thorac Soc       Date:  2008-12-01

10.  Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.

Authors:  Joseph Finkelstein; Eunme Cha; Steven M Scharf
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.